Cargando…

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

We compared morphologic computed tomography (CT)-based to metabolic fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/CT-based response evaluation in patients with metastatic colorectal cancer and correlated the findings with survival and KRAS status. From 2006 to 2009, patients were inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skougaard, Kristin, Johannesen, Helle Hjorth, Nielsen, Dorte, Schou, Jakob Vasehus, Jensen, Benny Vittrup, Høgdall, Estrid V S, Hendel, Helle Westergren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302679/ https://www.ncbi.nlm.nih.gov/pubmed/24941936 http://dx.doi.org/10.1002/cam4.271

Ejemplares similares

Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy
por: Matthiessen, Louise Wichmann, et al.
Publicado: (2013)

miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3(rd) Line Cetuximab and Irinotecan
por: Schou, Jakob V., et al.
Publicado: (2014)

Eosinophilic Cystitis Presenting as Possible Pediatric Rhabdomyosarcoma in Conventional Imaging Including (18)F-FDG-PET/CT/MRI—A Rare Case
por: Enevold Olsen, Naja, et al.
Publicado: (2021)

A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck
por: Adkins, Douglas, et al.
Publicado: (2014)

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
por: Palshof, Jesper Andreas, et al.
Publicado: (2017)

A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients
por: Dyrberg, Eva, et al.
Publicado: (2017)

18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
por: Thacker, Curtis A, et al.
Publicado: (2012)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer
por: Palshof, Jesper Andreas, et al.
Publicado: (2020)

Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer
por: Sobrero, Alberto, et al.
Publicado: (2020)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

18F-FDG PET/CT in a Case of Urothelial Carcinoma in the Urachus Presenting as Colon Cancer
por: Andersen, Jeannette D., et al.
Publicado: (2021)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol
por: Spindler, Nicklas Juel, et al.
Publicado: (2023)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
por: Demuth, Christina, et al.
Publicado: (2018)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

Comparative study of (18)F-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis
por: Ping, Bingqiong, et al.
Publicado: (2015)

Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial
por: Lipsyc-Sharf, Marla, et al.
Publicado: (2022)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability
por: Boisen, Mogens Karsbøl, et al.
Publicado: (2015)

Utilizing (18)F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
por: Momcilovic, Milica, et al.
Publicado: (2018)

The role of FDG-PET/CT in gynaecological cancers
por: Rockall, Andrea G, et al.
Publicado: (2012)

Lymphomatoid Granulomatosis: CT and FDG-PET Findings
por: Chung, Jonathan H., et al.
Publicado: (2011)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

The Importance of FDG-PET/CT in Cogan’s Syndrome
por: Örsal, Ebru, et al.
Publicado: (2014)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

Usefulness of FDG PET/CT in the management of tuberculosis
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2019)

Role of FDG PET/CT in Baastrup's disease
por: Subramanyam, Padma, et al.
Publicado: (2016)

FDG PET/CT Findings in Biliary Papillomatosis
por: Tu, Zhuolong, et al.
Publicado: (2020)

FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

FDG PET/CT in cancer: comparison of actual use with literature-based recommendations
por: Petersen, Henrik, et al.
Publicado: (2015)

PET/CT en patología oncológica /
Publicado: (2011)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

Riedel’s Thyroiditis with Intense FDG Uptake Demonstrated on FDG PET/CT
por: Mansberg, Robert, et al.
Publicado: (2015)

Ultrasound, CT and FDG PET-CT of a Duodenal Granuloma in a Dog
por: JEON, Sunghoon, et al.
Publicado: (2014)

Askin Tumor: CT and FDG-PET/CT Imaging Findings and Follow-Up
por: Xia, Tingting, et al.
Publicado: (2014)

4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT
por: Chi, Alexander, et al.
Publicado: (2014)

Diagnosis of an intestinal mucormycosis ‘fungus ball’ located with PET/CT with [(18)F] FDG-PET/CT
por: Gallo, Franklin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i2d8idi0k371m45jia949l0vp4